Biocon Board of Directors
Get the latest insights into the leadership at Biocon. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Ms. Kiran Mazumdar Shaw | Executive Chairperson |
| Mr. Siddharth Mittal | Managing Director & CEO |
| Prof. Ravi Rasendra Mazumdar | Non Exe.Non Ind.Director |
| Mr. Eric Vivek Mazumdar | Non Exe.Non Ind.Director |
| Mr. Bobby Kanubhai Parikh | Independent Director |
| Mr. Naina Lal Kidwai | Lead Independent Director |
| Ms. Rekha Mehrotra Menon | Independent Director |
| Mr. Nicholas Robert Haggar | Independent Director |
| Mr. Atul Dhawan | Independent Director |
Biocon Share price
BIOCON
356.85
4.70 (-1.30%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:59 IST
BUYSELL
Today's High
364.55
Today's Low
355.00
52 Week Low
291.00
52 Week High
406.00
The current prices are delayed, login to your account for live prices
LoginBiocon FAQs
The board at Biocon consists of experienced professionals, including Ms. Kiran Mazumdar Shaw , Mr. Siddharth Mittal , and others, overseeing the company’s strategic and corporate governance.
Directors at Biocon are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Ms. Kiran Mazumdar Shaw is the current chairman at Biocon.
Executive directors at Biocon are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Biocon adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Biocon, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.